•
China NT Pharma Group Company Ltd (HKG: 1011), a China-based pharmaceutical company, has announced the signing of a non-binding memorandum of understanding (MOU) with the Global New Normal Anti Inflation Limited Partner Fund. This cooperation is aimed at bolstering NT Pharma’s presence in the orthopedic products sector, with the fund…